http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/ Y! Health Lymphoma News, updated continuously. en-us Sun, 08 Nov 2009 10:29:28 PST Copyright (c) 2009 Yahoo! Inc. All rights reserved. 5 142 18 http://health.yahoo.com/ http://us.i1.yimg.com/us.yimg.com/i/us/he/b/he_144.gif http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/istodaxapprovedforcutaneoustcelllymphoma.htmlyahoo/health/news/healthday/istodaxapprovedforcutaneoustcelllymphomaFri, 06 Nov 2009 20:48:31 PSTHealthDay - FRIDAY, Nov. 6 (HealthDay News) -- The Gloucester Pharmaceuticals drug Istodax (romidepsin) has been approved by the U.S. Food and Drug Administration to treat cutaneous T-cell lymphoma (CTCL) in people who have tried at least one prior systemic therapy, the drug's manufacturer said in a news release.http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/us_bowel_disease_cancer.htmlyahoo/health/news/reuters/us_bowel_disease_cancerSun, 18 Oct 2009 16:28:04 PDTReuters - Some treatments for inflammatory bowel disease increase the risk of infection-related cancers, French scientists said on Monday, but the benefits of the drugs still outweigh the risks.